Immunization News and Research

RSS

Leeds project aims to boost parents' confidence in MMR choices as measles rates rise

With several hundred thousand unvaccinated children across the UK, health protection experts are hoping that new research at the University of Leeds will give parents better information about the MMR vaccine and lead to an increase in immunisation.

27 Jul 2008

U.S. tightens visas with vaccine requirements

New vaccine requirements will affect anyone who is applying for an immigrant visa for entry into the U.S. and anyone seeking adjustment of status for permanent residence.

23 Jul 2008

Advanced Cancer Therapeutics licenses technology to develop HPV vaccine

Advanced Cancer Therapeutics (ACT) has announced the signing of two new collaborative agreements that will advance development of the Company's novel human papillomavirus (HPV) vaccine program.

23 Jul 2008

Study looks at UK's controversial choice of HPV vaccine

The UK government may save up to £18.6 million a year by deciding to use the HPV vaccine Cervarix, given that it is equally effective as the more expensive Gardasil in preventing cervical abnormalities, according to a study published on BMJ.com.

19 Jul 2008

Superbug breakthrough

The week the government's chief medical officer for England, Sir Liam Donaldson, has announced that the NHS aims to create immunisation against two of the most common superbugs, MRSA and Clostridium difficile, within the next decade. But a research team led by University of Sunderland scientists has made a major breakthrough in the fight against a deadly hospital infection which kills tens of thousands of people every year, and it will be available within the next year.

17 Jul 2008

Worsening malnutrition and the threat of disease add to crisis in Ethiopia

Worsening malnutrition and the threat of disease outbreaks are compounding Ethiopia's humanitarian crisis. WHO is working with the Government of Ethiopia and health partners to support the 4.6 million people needing urgent emergency food relief nationwide.

13 Jul 2008

Fourth edition of the British National Formulary for Children

The fourth edition of the British National Formulary for Children (BNFC) arms health professionals with the information they need to tackle recent controversial health concerns in young people, including rising rates of teenage pregnancy and the increasing incidence of sexually transmitted infections.

3 Jul 2008

Jefferson scientists discover way to immunize mice against metastatic disease

Taking advantage of the fact that the intestines have a separate immune system from the rest of the body, scientists at the Kimmel Cancer Center at Jefferson in Philadelphia have found a way to immunize mice against the development of metastatic disease.

24 Jun 2008

Patch protects travellers from holiday diarrhoea

Scientists in the U.S. have developed a patch which protects people from stomach bugs picked up during foreign travel.

16 Jun 2008

Breastfeeding support lacking in U.S. hospitals and birth centers

Many birth facilities in the United States are not providing maternity care that is fully supportive of breastfeeding, according to a study in today's Morbidity and Mortality Weekly Reports (MMWR), a publication of the Centers for Disease Control and Prevention.

15 Jun 2008

Specific immune therapy works for many people with allergies

The German Institute for Quality and Efficiency in Health Care has assessed recent evidence on allergies. It found that the once controversial immune therapy against allergy symptoms can definitely help many people with allergies.

11 Jun 2008

Kaiser Permanente, Microsoft launch personal electronic health records pilot program

Officials from Kaiser Permanente and Microsoft on Monday announced that the companies are developing a patient information exchange pilot program, Reuters/Washington Post reports (Kaufman, Reuters/Washington Post, 6/9).

10 Jun 2008

Novel replacement for conventional needle and syringe

Chris Holden (21), A third year design student at Northumbria University, has won a prestigious national award for medical design by redesigning the conventional needle and syringe.

30 May 2008

US$28 million needed for Myanmar says WHO

WHO and its Health Cluster partners in Myanmar have launched a six-month and US$ 28 million action plan to provide immediate health care for cyclone survivors and to support longer-term efforts to rebuild the country's ravaged health system.

30 May 2008

Primate model for autism

A primate model for autism using the U.S. children's immunization schedule was unveiled at the International Meeting For Autism Research (IMFAR) this weekend.

20 May 2008

Getting sick in Victoria could be a worry

In what will be great concern to Australians living in Victoria, a newly released report has found that Victoria's hospitals have failed to meet key performance indicators.

15 May 2008

New data reveals impact of deadly human papillomavirus in Latin America, Caribbean

Thirty-three thousand women in Latin America and the Caribbean die each year of preventable cervical cancer, caused by a virus that infects 20 percent of men and women in the region and as many as 30 percent of the youngest women, according to a new study.

12 May 2008

The design of a vaccine against Leishmaniasis

The parasitology team at the "Severo Ochoa" Molecular biology centre (CSIC-UAM) has focused its research efforts on the search for a vaccine capable of activating immunity against the parasite that causes leishmaniasis.

7 May 2008

Mothers less likely to pursue HPV vaccination for youngest daughters

Because the first national study of its kind has found that U.S. mothers report they are less likely to vaccinate daughters under age 13 against human papillomavirus virus (HPV), even though the vaccine is recommended for girls at age 11 and 12, it's incumbent upon the healthcare community to work to improve moms' acceptance of the vaccination for younger daughters, say researchers at Cincinnati Children's Hospital Medical Center who conducted the study. HPV is a sexually transmitted virus known to cause cervical cancer.

30 Apr 2008

ImmunoVaccine Technologies patents DepoVax vaccine platform

ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, unveiled today its DepoVax platform, a novel depot vaccine delivery system used to increase the efficacy and strength of vaccines. IVT has filed additional patents to protect the DepoVax concept.

30 Apr 2008